Olga Rass1, Daniel J Fridberg2, Brian F O'Donnell3. 1. Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA. Electronic address: orass1@jhmi.edu. 2. Department of Psychological and Brain Sciences, Indiana University, 1101 East 10th Street, Bloomington, IN 47405, USA. Electronic address: dfridber@indiana.edu. 3. Department of Psychological and Brain Sciences, Indiana University, 1101 East 10th Street, Bloomington, IN 47405, USA; Department of Psychiatry, Indiana University School of Medicine, 340 West 10th Street, Suite 6200, Indianapolis, IN 46202, USA. Electronic address: bodonnel@indiana.edu.
Abstract
OBJECTIVES: Despite efforts that have increased smoking regulation, cigarette taxation, and social stigma, cigarette smoking remains the leading cause of preventable death worldwide, and a significant personal and public economic burden. In the U.S., intermittent smokers comprise approximately 22% of all smokers and represent a stable, non-dependent group that may possess protective factors that prevent the transition to dependence. One possibility is that intermittent smokers have intact CNS frontal regulatory and control mechanisms that enable resistance to nicotine-induced changes. METHODS: The present study measured inhibitory control using a flanker task and a go-nogo continuous performance tasks in daily dependent smokers, intermittent non-dependent smokers, and nonsmokers. Event-related potential (ERP) measures of were concurrently recorded to measure performance monitoring via Event-Related Negativity (ERN) and error positivity (Pe) components during error trials for each task. RESULTS: In both tasks, behavioral and ERN measures did not differ between groups; however, amplitude of the Pe component was largest among intermittent smokers. CONCLUSIONS: Thus, intermittent smokers differed from both daily smokers and nonsmokers on error processing, potentially revealing neuroprotective cognitive processes in nicotine dependence. SIGNIFICANCE: A better understanding of factors that mediate behavioral regulation may provide novel treatment approaches that help individuals achieve controlled smoking or cessation.
OBJECTIVES: Despite efforts that have increased smoking regulation, cigarette taxation, and social stigma, cigarette smoking remains the leading cause of preventable death worldwide, and a significant personal and public economic burden. In the U.S., intermittent smokers comprise approximately 22% of all smokers and represent a stable, non-dependent group that may possess protective factors that prevent the transition to dependence. One possibility is that intermittent smokers have intact CNS frontal regulatory and control mechanisms that enable resistance to nicotine-induced changes. METHODS: The present study measured inhibitory control using a flanker task and a go-nogo continuous performance tasks in daily dependent smokers, intermittent non-dependent smokers, and nonsmokers. Event-related potential (ERP) measures of were concurrently recorded to measure performance monitoring via Event-Related Negativity (ERN) and error positivity (Pe) components during error trials for each task. RESULTS: In both tasks, behavioral and ERN measures did not differ between groups; however, amplitude of the Pe component was largest among intermittent smokers. CONCLUSIONS: Thus, intermittent smokers differed from both daily smokers and nonsmokers on error processing, potentially revealing neuroprotective cognitive processes in nicotine dependence. SIGNIFICANCE: A better understanding of factors that mediate behavioral regulation may provide novel treatment approaches that help individuals achieve controlled smoking or cessation.
Authors: Jodie Feil; Dianne Sheppard; Paul B Fitzgerald; Murat Yücel; Dan I Lubman; John L Bradshaw Journal: Neurosci Biobehav Rev Date: 2010-03-17 Impact factor: 8.989
Authors: John R Fedota; Allison L Matous; Betty Jo Salmeron; Hong Gu; Thomas J Ross; Elliot A Stein Journal: Neuropsychopharmacology Date: 2016-04-26 Impact factor: 7.853
Authors: Kristen P Morie; Jia Wu; Marc N Potenza; Suchitra Krishnan-Sarin; Linda C Mayes; Christopher J Hammond; Michael J Crowley Journal: J Psychiatr Res Date: 2021-05-23 Impact factor: 4.791
Authors: Miranda Christine Lutz; Rianne Kok; Ilse Verveer; Marcelo Malbec; Susanne Koot; Pol A C van Lier; Ingmar H A Franken Journal: J Psychiatry Neurosci Date: 2021-11-09 Impact factor: 6.186